Edition:
United States

PAREXEL International Corp (PRXL.OQ)

PRXL.OQ on NASDAQ Stock Exchange Global Select Market

79.64USD
4:00pm EDT
Change (% chg)

$0.33 (+0.42%)
Prev Close
$79.31
Open
$80.25
Day's High
$80.38
Day's Low
$79.50
Volume
219,950
Avg. Vol
351,469
52-wk High
$80.38
52-wk Low
$51.18

PRXL.OQ

Chart for PRXL.OQ

About

PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device... (more)

Overall

Beta: 0.76
Market Cap(Mil.): $4,025.96
Shares Outstanding(Mil.): 50.76
Dividend: --
Yield (%): --

Financials

  PRXL.OQ Industry Sector
P/E (TTM): 34.96 139.31 17.29
EPS (TTM): 2.27 -- --
ROI: 8.79 2.29 -5.84
ROE: 20.55 0.06 -5.23

Deals of the day-Mergers and acquisitions

May 11 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Thursday:

May 11 2017

Starboard buys 5.7 percent stake in Parexel, joining other activists

Activist investor Starboard Value LP reported a 5.7 percent stake in Parexel International Corp on Thursday, saying the U.S. contract research firm's shares were "undervalued" and represented an attractive investment opportunity.

May 11 2017

UPDATE 3-Starboard buys 5.7 pct stake in Parexel, joining other activists

* Corvex also in the stock, sources say; Jana too - filing (Adds company statement, Corvex and Jana stake information, byline)

May 11 2017

Starboard reports 5.7 pct stake in contract research firm Parexel

May 11 Activist investor Starboard Value LP reported a 5.7 percent stake in Parexel International Corp on Thursday, calling the U.S. contract research firm's shares "undervalued" and that it represented an attractive investment opportunity.

May 11 2017

BRIEF-Starboard Value LP reports 5.7 pct stake in PAREXEL International

* Starboard value lp reports 5.7 percent stake in parexel international -sec filing

May 11 2017

BRIEF-Starboard Value has taken 5.7 pct stake in Parexel International- WSJ

* Activist investor Starboard Value LP has taken 5.7 percent stake in Parexel International Corp- WSJ, citing sources Source text : http://on.wsj.com/2q54d9R Further company coverage:

May 10 2017

INC Research to merge with inVentiv in latest contract medical research deal

INC Research Holdings Inc said on Wednesday it would merge with private equity-owned inVentiv Health Inc, a fellow contract research services provider, in a $4.6 billion all-stock deal to help it win contracts with large pharma companies.

May 10 2017

UPDATE 3-INC Research to merge with inVentiv in latest contract medical research deal

* INC shares rise 19 pct, biggest one-day pct jump ever (Adds comments from inVentiv CEO, analyst; updates shares)

May 10 2017

Contract research firm Parexel International explores sale-sources

Contract drug research firm Parexel International Corp is exploring a sale, sources familiar with the matter told Reuters on Monday.

May 08 2017

Deals of the day-Mergers and acquisitions

May 8 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Monday:

May 08 2017

More From Around the Web

Earnings vs. Estimates